Lung (includes NSCLC, SCLC, Mesothelioma)
Featured Articles
(Morningstar/Dow Jones Newswires) Dec 6, 2018 - Genentech, a member of the Roche Group, on Thursday said the U.S. Food and Drug Administration approved Tecentriq and chemotherapy for some patients with a certain type of lung cancer. Genentech said the FDA gave its approval to Tecentriq in combination with Avastin, paclitaxel and...
Read Article
(Reuters) Dec 5, 2018 - AbbVie Inc said on Wednesday it had halted enrollment for a late stage trial of Rova-T as a second-line therapy for advanced small-cell lung cancer, following recommendations made by an independent data monitoring committee. The committee’s recommendations were based on shorter overall survival in the Rova-T...
Read Article
Latest Articles
December 13, 2018
December 11, 2018
December 07, 2018
December 06, 2018
December 06, 2018
December 05, 2018
December 05, 2018
December 05, 2018
View More
News Commentary
Editor Image
07 Dec, 2018 | by H. Jack West, MD
While it's nice to have a new approval, this is also a setting in which the...
View Comment
Editor Image
05 Dec, 2018 | by H. Jack West, MD
This will be an important development for thoracic oncology. The results of the...
View Comment
View More
OBR Blog
There are no Lung (includes NSCLC, SCLC, Mesothelioma) blog entries.